On Jan. 1, Dave Ricks becomes CEO of drugmaker Eli Lilly and Co. as it tries to launch new products after a tough stretch of patent expirations. To prepare, Ricks has spent a lot of time with outgoing CEO John Lechleiter “learning from the master.”
Sue Ellspermann has been a lot of things in her life: industrial engineer, business consultant, university teacher, state legislator and—from 2013 until earlier this year—Indiana’s lieutenant governor. Now, the southwestern Indiana native has a new gig: president of Ivy Tech Community College of Indiana, which she started July 1.
Mayor Joe Hogsett's administration is targeting the former General Motors stamping plant site on the west side, where development plans have stalled, and the upstart Market East District on the opposite end of downtown.
Employers began hiring health advocates in earnest nationwide about four years ago, fueled by implementation of the Affordable Care Act and growing public awareness that provider rates and quality can differ greatly.
The case centered on an 80-year-old dilapidated hospital in eastern Indiana that St. Vincent bought in 2000. St. Vincent replaced it with a new hospital, called St. Vincent Randolph, at a cost of about $15.5 million.
CNO Financial Group Inc. said it ended a risk-transfer deal with a reinsurer tied to embattled hedge fund Platinum Partners and has filed suit against executives of Beechwood Re. CNO shares tumbled after the news.
Pharma giant Novo Nordisk announced Thursday that it is cutting 1,000 jobs after slashing forecasts for 2016, citing lower prices for diabetes drugs. Novo and competitors such as Indianapolis-based Eli Lilly will likely have to keep tightening their belts as prices and profit margins fall, experts say.